: Finding ways to help patients manage side effects so they can stay on the therapy longer.
This article, available through PubMed Central (PMC) , provides a comprehensive look at how the drug performs in real-world clinical settings compared to controlled trials. Study Overview: The 616-Patient Cohort (616 KB)
: Both groups had roughly the same time (about 85–87 months) from their initial diagnosis until they started ibrutinib treatment. Clinical Implications : Finding ways to help patients manage side
The authors argue that because the drug is highly effective but often hard to tolerate, the medical community should focus on: available through PubMed Central (PMC)
Provide a breakdown of the used by the researchers in this study. Which of these would be most helpful for you?